Northstar Global Business Services

MDIN · OTC

$0.00+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About MDIN

MedGen, Inc. engages in the manufacture, sale, and licensing of healthcare products. The company is headquartered in Boca Raton, Florida. The company went IPO on 2000-06-07. The firm's products are distributed via direct online sales, as well as retail distribution through its partners, and individual stores. Its products include SNORenz, SNORenz Night Time, Health Enrich for Pets, Stem-Intense and Wide Awake. The company others products include Sombium, Focamine and Relaxapro. SNORenz is a lubricating throat spray. SNORenz Night Time is also a lubricating throat spray and natural supplement sleep aid. Health Enrich for Pets is an anti-inflammatory and a catalyst that causes the body to be flooded with adult stem cells. Stem-Intense is a supplement for producing adult stem cells. Wide Awake is an energy spray and breath freshener. Sombium is a chemical-free sleep aid. Focamine is a concentration promoter. Relaxapro is an anti-anxiety medicine.

Employees
0
Headquarters
Boca Raton, Florida
Listed
Jun 7, 2000
Sector
Health Care
Industry
Pharmaceuticals

MDIN key statistics

Market cap
3.01K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
356.55K
Volume
100.00K
Open price
$0.00
High today
$0.00
Low today
$0.00
52 Week high
$0.00
52 Week low
$0.00

Northstar Global Business Services (MDIN) at a glance

As of Oct 8, 2026, Northstar Global Business Services (MDIN) shares are priced at $0.00, giving the company a market cap of 3.01K and a price-to-earnings ratio of 0.00.

Volume so far is 100.00K shares, below the average of 356.55K shares a day.

Similar companies

Companies in the same industry as Northstar Global Business Services

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.